TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

RUBY-FILL

RUBIDIUM CHLORIDE RB-82
Approved 2016-09-30
1
Indication
--
Phase 3 Trials
9
Years on Market

Details

Status
Prescription
First Approved
2016-09-30
Routes
INTRAVENOUS
Dosage Forms
SOLUTION

Companies

Active Ingredient: RUBIDIUM CHLORIDE RB-82

RUBY-FILL Approval History

Loading approval history...

What RUBY-FILL Treats

1 indications

RUBY-FILL is approved for 1 conditions since its original approval in 2016. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Coronary Artery Disease
Source: FDA Label

RUBY-FILL Boxed Warning

HIGH LEVEL RADIATION EXPOSURE WITH USE OF INCORRECT ELUENT AND FAILURE TO FOLLOW QUALITY CONTROL TESTING PROCEDURE High Level Radiation Exposure with Use of Incorrect Eluent Patients are exposed to high radiation levels when the generator is eluted with the incorrect eluent due to high Sr 82 and Sr 85 breakthrough levels [see Warnings and Precautions ( 5.1 )] Use only additive-free 0.9% Sodium Chloride Injection USP to elute the generator [see Dosage and Administration ( 2.5 )] Immediately stop ...

Drugs Similar to RUBY-FILL

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
AMLODIPINE BESYLATE
1 shared
Viatris
Shared indications:
Coronary Artery Disease
AMLODIPINE BESYLATE AND VALSARTAN
AMLODIPINE BESYLATE
1 shared
ALEMBIC
Shared indications:
Coronary Artery Disease
AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE
AMLODIPINE BESYLATE
1 shared
STRIDES PHARMA INTL
Shared indications:
Coronary Artery Disease
AMMONIA N 13
AMMONIA N-13
1 shared
BIOMEDCL RES FDN
Shared indications:
Coronary Artery Disease
BRILINTA
TICAGRELOR
1 shared
AstraZeneca
Shared indications:
Coronary Artery Disease
CADUET
AMLODIPINE BESYLATE
1 shared
PHARMACIA
Shared indications:
Coronary Artery Disease
CARDIOGEN-82
RUBIDIUM CHLORIDE RB-82
1 shared
BRACCO
Shared indications:
Coronary Artery Disease
CARDIOLITE
TECHNETIUM TC-99M SESTAMIBI KIT
1 shared
LANTHEUS MEDCL
Shared indications:
Coronary Artery Disease
FLYRCADO
FLURPIRIDAZ F-18
1 shared
GE HLTHCARE
Shared indications:
Coronary Artery Disease
GADAVIST
GADOBUTROL
1 shared
Bayer
Shared indications:
Coronary Artery Disease
IODIXANOL
IODIXANOL
1 shared
HENGRUI PHARMA
Shared indications:
Coronary Artery Disease
KATERZIA
AMLODIPINE BENZOATE
1 shared
AZURITY
Shared indications:
Coronary Artery Disease
MONOKET
ISOSORBIDE MONONITRATE
1 shared
OMNIVIUM PHARMS
Shared indications:
Coronary Artery Disease
MYOVIEW
TECHNETIUM TC-99M TETROFOSMIN KIT
1 shared
MEDI-PHYSICS
Shared indications:
Coronary Artery Disease
NITRO-DUR
NITROGLYCERIN
1 shared
USPHARMA
Shared indications:
Coronary Artery Disease
NITROGLYCERIN
NITROGLYCERIN
1 shared
RUBICON RESEARCH
Shared indications:
Coronary Artery Disease
NITROLINGUAL PUMPSPRAY
NITROGLYCERIN
1 shared
POHL BOSKAMP
Shared indications:
Coronary Artery Disease
NITROMIST
NITROGLYCERIN
1 shared
EVUS
Shared indications:
Coronary Artery Disease
NORLIQVA
AMLODIPINE BESYLATE
1 shared
CMP DEV LLC
Shared indications:
Coronary Artery Disease
NORVASC
AMLODIPINE BESYLATE
1 shared
Viatris
Shared indications:
Coronary Artery Disease
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

RUBY-FILL FDA Label Details

Pro

Indications & Usage

FDA Label (PDF)

RUBY-FILL is a closed system used to produce rubidium Rb 82 chloride injection for intravenous administration. Rubidium Rb 82 chloride injection is indicated for Positron Emission Tomography (PET) imaging of the myocardium under rest or pharmacologic stress conditions to evaluate regional myocardial perfusion in adult patients with suspected or existing coronary artery disease. RUBY-FILL is a closed system used to produce rubidium Rb 82 chloride injection for intravenous use. Rubidium Rb 82 chloride injection is a radioactive diagnostic agent indicated for Positron Emission Tomography (PET) im...

⚠️ BOXED WARNING

WARNING: HIGH LEVEL RADIATION EXPOSURE WITH USE OF INCORRECT ELUENT AND FAILURE TO FOLLOW QUALITY CONTROL TESTING PROCEDURE High Level Radiation Exposure with Use of Incorrect Eluent Patients are exposed to high radiation levels when the generator is eluted with the incorrect eluent due to high Sr 8...

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.